Prostate cancer treatment tied to hernia risk
By Kerry Grens NEW YORK (Reuters Health) - Prostate removal or radiation therapy to treat cancer is tied to two- to four-fold higher...
Read More »Health News
Subscribe to the Health News feed.-
-
U.S. doctor group votes to recognize obesity as a disease
By Nick Carey CHICAGO (Reuters) - In order to fight what it described as an "obesity epidemic," the American Medical Association vot...
Read More » -
Exclusive - Forest keen to bid for Irish drugmaker Elan - sources
By Jessica Toonkel and Soyoung Kim NEW YORK (Reuters) - Forest Laboratories Inc, the specialty drugmaker that counts investor Carl I...
Read More » -
Cervical cancer vaccines cut rates of HPV infections: U.S
CHICAGO (Reuters) - The U.S. introduction of a vaccine to prevent cervical cancer in 2006 has reduced infections with the human papi...
Read More » -
Niche drugmaker ViroPharma attracts takeover interest: sources
By Jessica Toonkel NEW YORK (Reuters) - ViroPharma Inc, a drug maker specializing in rare diseases, is attracting preliminary acquis...
Read More » -
New Hampshire nears approval of medical marijuana law
By Jason McLure LITTLETON, New Hampshire (Reuters) - New Hampshire is set to become the final state in New England to allow medical ...
Read More » -
New 'Obamacare' exchanges could miss enrollment deadline - GAO
By David Morgan and Caroline Humer (Reuters) - New health insurance exchanges being set up by the federal government in more than 30...
Read More » -
Hot flashes common even before menopause
By Kathryn Doyle NEW YORK (Reuters Health) - Most women expect hot flashes as a part of the "change of life," but more than half sta...
Read More » -
EU fines Lundbeck and others 146 million euros for blocking rival drugs
By Foo Yun Chee BRUSSELS (Reuters) - European antitrust regulators fined nine drugmakers, including Denmark's Lundbeck, a total of 1...
Read More » -
AstraZeneca, Bristol diabetes drug disappoints in key test
By Ben Hirschler LONDON (Reuters) - AstraZeneca and Bristol-Myers Squibb's diabetes drug Onglyza failed to reduce heart risks in a l...
Read More »